|
Ludwig Cancer Research is an international community of scientists focused on cancer research, with the goals of preventing and controlling cancer.〔(【引用サイトリンク】url=http://www.ludwigcancerresearch.org/our-story/about-us/institute )〕 It encompasses the Ludwig Institute for Cancer Research, an international non-profit organization founded in 1971 by philanthropist Daniel K. Ludwig. The Institute is headquartered in New York City with a European office located in Zurich. In addition, six Ludwig Centers were established at leading US cancer research institutions. Together, the Institute and Centers are known as Ludwig Cancer Research. Since its founding in 1971, Ludwig Cancer Research has committed more than (US) $2.5 billion to cancer research. Ludwig Cancer Research focuses on both basic research and translational research, with specific emphasis on cell biology, genomics, immunology, neuroscience, prevention, cell signaling, stem cells, therapeutics, and tumor biology, as well as clinical trials and the design and development of small molecules with drug-like properties. Its researchers also focus on particular types of malignancy, including brain cancer, breast cancer, colon cancer, and melanoma.〔(【引用サイトリンク】url=http://www.ludwigcancerresearch.org/our-science/research-areas/collaborative-areas )〕 ==Founder and history== Daniel K. Ludwig was a shipping magnate and real estate investor. Born in South Haven, Michigan in 1897, he parleyed a $5,000 loan from his father into a global business empire based on a fleet of supertankers. In the 1960s and 1970s, Ludwig was among the richest men in the world, with a self-made empire of some 200 companies globally. He founded the Ludwig Institute for Cancer Research as an independent organization in 1971, the same year that the “War on Cancer,” declared by his friend President Richard Nixon, led to the establishment of the US National Cancer Institute. Ludwig believed that tackling the problem of cancer required the best minds operating in the most favorable conditions with the best resources to accomplish the task. This principle continues to guide Ludwig Cancer Research. Daniel K. Ludwig endowed the Institute with all of the foreign assets from his business holdings. Upon his death in 1992, that endowment had grown to more than $700 million,〔 and it stands at more than $1.3 billion today.〔 After Ludwig’s death, his US-based assets were also put into a trust to support additional cancer research efforts. These funds led to the establishment of Ludwig Centers at six research institutions in 2006. The Ludwig Institute for Cancer Research and Ludwig Centers have been known collectively as Ludwig Cancer Research since 2012.〔(【引用サイトリンク】url=http://www.ludwigcancerresearch.org/sites/default/files/media/news-pdf/Ludwig_Annual_2012.pdf )〕 In total, Ludwig Cancer Research has committed more than (US) $2.5 billion to cancer research worldwide since 1971. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Ludwig Cancer Research」の詳細全文を読む スポンサード リンク
|